openPR Logo
Press release

Exploring the Future of Biosimilars: Market Growth, Trends, and COVID-19 Impact from 2023 to 2031

Exploring the Future of Biosimilars

Exploring the Future of Biosimilars

๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง
The biosimilar market is experiencing rapid growth as healthcare systems worldwide recognize the cost-saving potential and therapeutic efficacy of these drugs. Biosimilars are biologic medical products that are almost identical to original branded drugs but are typically more affordable. This blog post provides an in-depth analysis of the global biosimilar market size, share, and the impact of COVID-19. We will also explore market segmentation by resin type, application, technology, end-use industry, and regional forecasts from 2023 to 2031.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž ๐š๐ง๐ ๐’๐ก๐š๐ซ๐ž
In 2023, the global biosimilar market was valued at approximately $X billion and is expected to grow at a CAGR of Y% during the forecast period. The increasing demand for cost-effective biologics, coupled with the expiration of patents for blockbuster biologics, drives the market growth. Key players include Sandoz, Teva Pharmaceuticals, and Pfizer, who lead with extensive portfolios and robust R&D investments.

๐†๐ž๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐”๐ง๐ข๐ช๐ฎ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ- https://www.accuteresearch.com/request-for-free-sample/8194

๐‚๐Ž๐•๐ˆ๐ƒ-๐Ÿ๐Ÿ— ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ
The COVID-19 pandemic had a profound impact on the biosimilar market. Initially, the market faced challenges such as supply chain disruptions and delayed clinical trials. However, the pandemic also accelerated the adoption of biosimilars due to the urgent need to reduce healthcare costs and ensure the availability of essential treatments. Post-pandemic, the market is witnessing a surge in biosimilar approvals and launches, signaling strong growth prospects.

๐๐ฒ ๐‘๐ž๐ฌ๐ข๐ง ๐“๐ฒ๐ฉ๐ž
Protein-based Biosimilars: These dominate the market due to their extensive use in treating chronic diseases like cancer and autoimmune disorders.
Non-protein Biosimilars: Emerging segment with potential applications in new therapeutic areas.

๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
Oncology: The largest application segment, driven by the high prevalence of cancer and the need for affordable biologic therapies.
Autoimmune Diseases: Significant growth due to the rising incidence of diseases like rheumatoid arthritis and psoriasis.
Chronic Diseases: Increasing demand for biosimilars to treat conditions such as diabetes and growth hormone deficiencies.

๐๐ฒ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ
Recombinant DNA Technology: The predominant technology used in the production of biosimilars, ensuring high efficacy and safety.
Monoclonal Antibody Technology: A growing segment due to its specificity and effectiveness in targeting disease pathways.

๐๐ฒ ๐„๐ง๐-๐”๐ฌ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
Hospitals: Major end-users, as hospitals are the primary centers for biologic treatments.
Specialty Clinics: Increasingly important due to the rise in outpatient treatments and specialized care.
Pharmacies: Growing segment as biosimilars become more accessible to patients through retail and online pharmacies.

๐…๐ซ๐ž๐ž ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ- https://www.accuteresearch.com/request-for-customization/8194

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ

๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š
Market Leader: Dominates the market due to advanced healthcare infrastructure, high R&D investment, and favorable regulatory frameworks.
Growth Drivers: Increased adoption of biosimilars, patent expirations, and supportive government policies.
๐„๐ฎ๐ซ๐จ๐ฉ๐ž
Key Markets: Germany, France, and the UK lead in market size and growth.
Trends: Strong biosimilar uptake due to cost-containment measures and robust regulatory support from agencies like the EMA.
๐€๐ฌ๐ข๐š-๐๐š๐œ๐ข๐Ÿ๐ข๐œ
Emerging Market: Rapid growth attributed to increasing healthcare access, rising chronic disease burden, and supportive regulatory policies.
Challenges: Regulatory complexities and need for greater healthcare investment.
๐‹๐š๐ญ๐ข๐ง ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š ๐š๐ง๐ ๐Œ๐ข๐๐๐ฅ๐ž ๐„๐š๐ฌ๐ญ & ๐€๐Ÿ๐ซ๐ข๐œ๐š
Growth Potential: Moderate growth expected due to improving healthcare infrastructure and increasing awareness of biosimilars.
Challenges: Economic constraints and limited access to advanced biologic therapies.

๐€๐ฌ๐ค ๐š๐›๐จ๐ฎ๐ญ ๐ฉ๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ข๐ง๐  ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐ฌ๐ฉ๐ž๐œ๐ข๐š๐ฅ ๐๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ- https://www.accuteresearch.com/buying-inquiry/8194

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

S NO 35/2, Bandhutva, Shiv Colony, Near Bus Stop, Pune-411043

info@accuteresearch.com

+91 92092 37178

๐€๐›๐จ๐ฎ๐ญ ๐€๐œ๐œ๐ฎ๐ญ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Accute Market Research is a prominent provider of market research and consulting services across diverse industries. The company offers extensive customized services for businesses and investors of all sizes worldwide.

Accute Market Research focuses on combining specialized market knowledge and research insights to consistently deliver exceptional results for our clients.

We specialize in technology, healthcare, aerospace & defence, automotive, agriculture, energy & power, and chemicals & materials industry verticals. The company provides market research, competitive intelligence, sentiment analysis, voice of customer, and strategic consulting services to companies worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exploring the Future of Biosimilars: Market Growth, Trends, and COVID-19 Impact from 2023 to 2031 here

News-ID: 3495459 • Views: โ€ฆ

More Releases from ๐€๐œ๐œ๐ฎ๐ญ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Global VEGF Inhibitor Drugs Market: Size, Share, and COVID-19 Impact Analysis
Global VEGF Inhibitor Drugs Market: Size, Share, and COVID-19 Impact Analysis
๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง The global market for VEGF (Vascular Endothelial Growth Factor) inhibitor drugs has seen substantial growth in recent years. These drugs play a critical role in the treatment of various cancers and age-related macular degeneration by inhibiting the VEGF pathway, which is pivotal in the formation of new blood vessels. This blog post delves into the market size, share, and the impact of COVID-19 on this sector, alongside an analysis byโ€ฆ
Exploring the Global Bone Growth Stimulant Market: Size, Share, and COVID-19 Impact Analysis (2023-2031)
Exploring the Global Bone Growth Stimulant Market: Size, Share, and COVID-19 Imp โ€ฆ
๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง: The global bone growth stimulant market has been experiencing significant growth, fueled by advancements in medical technology, rising geriatric population, and increasing prevalence of orthopedic conditions. However, the COVID-19 pandemic has introduced unprecedented challenges and opportunities for the market. In this blog, we delve into the size, share, and impact of various factors shaping the global bone growth stimulant market from 2023 to 2031. โ€ฆ
"Global TLR8 Market: Size, Share & COVID-19 Impact (2023-2031)
๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง: The global Toll-Like Receptor 8 (TLR8) market has been witnessing significant growth, driven by advancements in immunology research, increasing prevalence of infectious diseases, and rising demand for targeted therapies. However, the emergence of the COVID-19 pandemic has introduced new challenges and opportunities for the market. In this blog, we explore the size, share, and impact of various factors shaping the global TLR8 market from 2023โ€ฆ
"Global Goodpasture Syndrome Treatment: Dynamics & COVID-19 Impact (2023-2031)"
๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง: The global market for Goodpasture syndrome treatment has been witnessing steady growth, driven by advancements in medical research, improved diagnostic techniques, and a better understanding of autoimmune diseases. The COVID-19 pandemic has brought both challenges and opportunities for the market, reshaping healthcare priorities and accelerating digital health solutions. In this blog, we delve into the size, share, and impact of various factors shaping the globalโ€ฆ

All 5 Releases


More Releases for Biosimilars

Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog โ€ฆ
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depthโ€ฆ
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv โ€ฆ
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stemโ€ฆ
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco โ€ฆ
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, โ€˜Oncology Biosimilars Market Global Report 2020-30โ€™ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It isโ€ฆ
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar โ€ฆ
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, โ€˜Biosimilars Market Global Report 2020-30โ€™ states that the worldwide biosimilars market wasโ€ฆ
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi โ€ฆ
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompassโ€ฆ
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac โ€ฆ
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 millionโ€ฆ